Spiramicine

Spiramycin

Trade Name:

Spiramicine

Product Code:

SA00358

Active Substance:

Spiramycin

Dosage/Volume:

750 000 UI

Pharmaceutical Form:

Tablets

Package:

Box x 30

ATC Classification System:

J Antiinfectives for Systemic Use

OTC:

No

RX:

Yes

Product Registration:

Albania, Congo

Spiramicine – 750 000 UI Tablets

Spiramicine is a macrolide antibiotic that has similar uses with erythromycin. Macrolides are weak bases; their activity increases at alkaline pH. Macrolides penetrate into the pleural fluid, in the ascitic fluid, in the middle ear exudates and in the sputum. When the meninges are inflamed, they can enter in the cerebrospinal fluid. Macrolides are used in respiratory tract, urogenital, digestive and skin soft tissue infections, especially when beta-lactamic antibiotics or tetracyclines are contraindicated.

Spiramicine is indicated in:
• the treatment of otorhinolaryngological, bronchopulmonary, stomathological, genital (especially of prostate origin), bone and skin infections;
• the prophylaxis of meningitis by meningococcus;
• the cases when rifampicin is contraindicated;
• the toxoplasmosis of old women.

ATC CODE:
J01FA02

Shelf life:
36 months